(AP) — Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for ...
Pfizer and BioNTech, makers of the Food and Drug Administration-approved COVID-19 vaccine Comirnaty, shared today that their vaccine is effective among children ages 5 to 11 and that they will seek ...
New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants ...
Oct 13 (Reuters) - Pfizer Inc (PFE.N), opens new tab will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works in a wider age group. While ...
The announcement Monday from Pfizer and its German partner BioNTech that their coronavirus vaccine appears to be 90% effective thrilled medical experts around the world and presented a glimmer of hope ...
Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
COVID-19 vaccines for children between the ages of 5 and 11 could get the green light from the US Food and Drug Administration sometime this fall, Dr. Anthony Fauci said. "If you look at the studies ...
(AP) - New research suggests Pfizer’s COVID-19 vaccine can protect against a mutation found in the two more-contagious variants of the coronavirus that have erupted in Britain and South Africa. The ...
New research suggests that Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa. Those variants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results